Epoetin alfa biosimilar (Biosidus)

阿法依伯汀生物类似药 (Biosidus)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (Biosidus)
Drug Alias Name阿法依伯汀生物仿制药 (Biosidus)Hemax (Epoetin alfa)EpoimmunEpoyetZyrop +[7
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiosidus
China Registration ClassN/A

Develop Information

Active CompaniesBiosidus
Inactive CompaniesBio Sidus Sa
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A